Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(22 sites)

United States

Children's of Alabama, Birmingham, Alabama

Arkansas Children's Hospital, Little Rock, Arkansas

Children's Hospital Colorado, Aurora, Colorado

Yale-New Haven Children's Hospital, New Haven, Connecticut

University of Florida -UF Health, Gainesville, Florida